RBC Cuts Price Target on Inovio Pharmaceuticals to $8 From $11, Keeps Sector Perform, Speculative Risk
RBC Cuts Price Target on Inovio Pharmaceuticals to $8 From $11, Keeps Sector Perform, Speculative Risk
加拿大皇家銀行將伊諾維奧製藥的目標價從11美元下調至8美元，仍將其評級爲「板塊表現」，存在投機風險。
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登入免費觀看全文
登入/註冊